177 related articles for article (PubMed ID: 3277464)
21. Detection of antibodies to Plasmodium vivax by indirect immunofluorescence: influence of the geographic origin of antigens and serum samples.
Benzerroug EH; Demedts P; Wéry M
Am J Trop Med Hyg; 1986 Mar; 35(2):255-8. PubMed ID: 3513643
[TBL] [Abstract][Full Text] [Related]
22. [Detection of antibodies to vivax-malaria by ELISA using in vitro cultured erythrocytic Plasmodium cynomolgi as antigen].
Wang XZ; Li ST; Xi YH; Ye JS; Zhou ZX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(1):29-31. PubMed ID: 3289786
[No Abstract] [Full Text] [Related]
23. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.
Peiris JS; Premawansa S; Ranawaka MB; Udagama PV; Munasinghe YD; Nanayakkara MV; Gamage CP; Carter R; David PH; Mendis KN
Am J Trop Med Hyg; 1988 Jul; 39(1):26-32. PubMed ID: 3041855
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate.
Tachibana M; Sato C; Otsuki H; Sattabongkot J; Kaneko O; Torii M; Tsuboi T
Vaccine; 2012 Feb; 30(10):1807-12. PubMed ID: 22245309
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
[TBL] [Abstract][Full Text] [Related]
26. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates.
Sattabongkot J; Tsuboi T; Hisaeda H; Tachibana M; Suwanabun N; Rungruang T; Cao YM; Stowers AW; Sirichaisinthop J; Coleman RE; Torii M
Am J Trop Med Hyg; 2003 Nov; 69(5):536-41. PubMed ID: 14695092
[TBL] [Abstract][Full Text] [Related]
27. Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions.
Aguiar JC; Albrecht GR; Cegielski P; Greenwood BM; Jensen JB; Lallinger G; Martinez A; McGregor IA; Minjas JN; Neequaye J; Patarroyo ME; Sherwood JA; Howard RJ
Am J Trop Med Hyg; 1992 Nov; 47(5):621-32. PubMed ID: 1449203
[TBL] [Abstract][Full Text] [Related]
28. Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?
Mendis KN; David PH; Carter R
Immunol Today; 1991 Mar; 12(3):A34-7. PubMed ID: 2069676
[TBL] [Abstract][Full Text] [Related]
29. Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.
Mendis KN; Munesinghe YD; de Silva YN; Keragalla I; Carter R
Infect Immun; 1987 Feb; 55(2):369-72. PubMed ID: 2879793
[TBL] [Abstract][Full Text] [Related]
30. Plasmodium gallinaceum as antigen in immunofluorescence antibody studies.
Kielmann A; Weiss N
Acta Trop; 1968; 25(2):185-7. PubMed ID: 4386698
[No Abstract] [Full Text] [Related]
31. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
[TBL] [Abstract][Full Text] [Related]
32. Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types.
Handunnetti SM; Mendis KN; David PH
J Exp Med; 1987 May; 165(5):1269-83. PubMed ID: 3553414
[TBL] [Abstract][Full Text] [Related]
33. Detection of P. vivax antigens in malaria endemic populations of Nepal by ELISA using monoclonal antibodies raised against Thai isolates.
Joshi HH; Mahakunkijcharoen Y; Tantivanich S; Sharma AP; Khusmith S
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):828-33. PubMed ID: 15916076
[TBL] [Abstract][Full Text] [Related]
34. Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein.
David PH; Hudson DE; Hadley TJ; Klotz FW; Miller LH
J Immunol; 1985 Jun; 134(6):4146-52. PubMed ID: 3989306
[TBL] [Abstract][Full Text] [Related]
35. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
[TBL] [Abstract][Full Text] [Related]
36. Parasitized erythrocyte membrane antigens of Plasmodium brasilianum: relationships with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
Sulzer AJ; Collins WE; Cantella RA; Carney WP
Am J Trop Med Hyg; 1995 Dec; 53(6):618-23. PubMed ID: 8561264
[TBL] [Abstract][Full Text] [Related]
37. Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax.
Kumar N; Folgar JP; Lubega P
Am J Trop Med Hyg; 1992 Oct; 47(4):422-8. PubMed ID: 1279995
[TBL] [Abstract][Full Text] [Related]
38. Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax.
Romero P; Heimer EP; Herrera S; Felix AM; Nussenzweig RS; Zavala F
J Immunol; 1987 Sep; 139(5):1679-82. PubMed ID: 2442254
[TBL] [Abstract][Full Text] [Related]
39. Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax.
Cochrane AH; Nardin EH; de Arruda M; Maracic M; Clavijo P; Collins WE; Nussenzweig RS
Am J Trop Med Hyg; 1990 Nov; 43(5):446-51. PubMed ID: 2122747
[TBL] [Abstract][Full Text] [Related]
40. Cross-reacting antigens to Pc96, a protective antigen of Plasmodium chabaudi, in P. falciparum, P. vivax, and P. cynomolgi.
Wanidworanun C; Barnwell JW; Nagasawa H; Aikawa M; Shear H
Am J Trop Med Hyg; 1989 Jun; 40(6):579-84. PubMed ID: 2472747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
